https://www.selleckchem.com/products/ABT-737.html
Regenerative medicine provides promising approaches for treating chronic liver diseases. Previous studies indicate that decellularized liver architecture is damaged by invading non-hepatic inflammatory cells. This study aimed to use anti-inflammatory and regenerative potency of bone marrow-derived mesenchymal stem cells (BM-MSC) and prednisolone for reducing fibrosis and balancing inflammatory cell migration into the decellularized liver scaffold. The liver was decellularized by perfusing Sodium Lauryl Ether Sulfate (SLES), and nuclei d
Like
Comment
Share
